Prospective longitudinal study of coagulation profiles in children with hypoplastic left heart syndrome from stage I through Fontan completion

Journal of Thoracic and Cardiovascular Surgery

Volumn 137, Issue 4, 2009, Pages 934-941

  Odegard, Kirsten C ^a   Zurakowski, David ^a   DiNardo, James A ^a   Castro, Robert A ^a   McGowan Jr , Francis X ^a   Neufeld, Ellis J ^a   Laussen, Peter C ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; WARFARIN;

ARTICLE; BLOOD CLOTTING; CLINICAL ARTICLE; CONTROLLED STUDY; FONTAN PROCEDURE; HEART TRANSPLANTATION; HEMODYNAMICS; HUMAN; HYPOPLASTIC LEFT HEART SYNDROME; NEWBORN; PRIORITY JOURNAL; SURGICAL TECHNIQUE;

BLOOD COAGULATION DISORDERS; BLOOD COAGULATION TESTS; CHILD; CHILD, PRESCHOOL; FACTOR VIII; FONTAN PROCEDURE; HUMANS; HYPOPLASTIC LEFT HEART SYNDROME; INFANT; INFANT, NEWBORN; PROSPECTIVE STUDIES; THROMBOSIS;

EID: 62849104003     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2008.09.031     Document Type: Article

References (37)

1. d'Udekem Y., Iyengar A.J., Cochrane A.D., Grigg L.E., Ramsay J.M., Wheaton G.R., et al. The Fontan procedure: contemporary techniques have improved long-term outcomes. Circulation 116 (2007) I157-I164
2. McCrindle B.W., Williams R.V., Mitchell P.D., Hsu D.T., Paridon S.M., Atz A.M., et al. Relationship of patient and medical characteristics to health status in children and adolescents after the Fontan procedure. Circulation 113 (2006) 1123-1129
3. Khairy P., Fernandes S.M., Mayer Jr. J.E., Triedman J.K., Walsh E.P., Lock J.E., et al. Long-term survival, modes of death, and predictors of mortality in patients with Fontan surgery. Circulation 117 (2008) 85-92
4. Monagle P., Cochrane A., McCrindle B., Benson L., Williams W., and Andrew M. Thromboembolic complications after Fontan procedures: the role of prophylactic anticoagulation. J Thorac Cardiovasc Surg 115 (1998) 493-498
5. du Plessis A.J., Chang A.C., Wessel D.L., Lock J.E., Wernovsky G., Newburger J.W., et al. Cerebrovascular accidents following the Fontan operation. Pediatr Neurol 12 (1995) 230-236
6. Rosenthal D.N., Friedman A.H., Kleinman C.S., Kopf G.S., Rosenfeld L.E., and Hellenbrand W.E. Thromboembolic complications after Fontan operations. Circulation 92 9 Suppl (1995) II287-II293
7. Jahangiri M., Ross D.B., Redington A.N., Lincoln C., and Shinebourne E.A. Thromboembolism after the Fontan procedure and its modifications. Ann Thorac Surg 58 (1994) 1409-1413 discussion 13-4
8. Balling G., Vogt M., Kaemmerer H., Eicken A., Meisner H., and Hess J. Intracardiac thrombus formation after the Fontan operation. J Thorac Cardiovasc Surg 119 (2000) 745-752
9. Monagle P., and Karl T.R. Thromboembolic problems after the Fontan operation. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu 5 (2002) 36-47
10. Odegard K.C., McGowan Jr. F.X., Zurakowski D., DiNardo J.A., Castro R.A., del Nido P.J., et al. Coagulation factor abnormalities in patients with single-ventricle physiology immediately prior to the Fontan procedure. Ann Thorac Surg 73 (2002) 1770-1777
11. Odegard K.C., McGowan Jr. F.X., DiNardo J.A., Castro R.A., Zurakowski D., Connor C.M., et al. Coagulation abnormalities in patients with single-ventricle physiology precede the Fontan procedure. J Thorac Cardiovasc Surg 123 (2002) 459-465
12. Cromme-Dijkhuis A.H., Hess J., Hahlen K., Henkens C.M., Bink-Boelkens M.T., Eygelaar A.A., et al. Specific sequelae after Fontan operation at mid- and long-term follow-up: arrhythmia, liver dysfunction, and coagulation disorders. J Thorac Cardiovasc Surg 106 (1993) 1126-1132
13. Jahangiri M., Kreutzer J., Zurakowski D., Bacha E., and Jonas R.A. Evaluation of hemostatic and coagulation factor abnormalities in patients undergoing the Fontan operation. J Thorac Cardiovasc Surg 120 (2000) 778-782
14. Odegard K.C., McGowan Jr. F.X., Zurakowski D., DiNardo J.A., Castro R.A., del Nido P.J., et al. Procoagulant and anticoagulant factor abnormalities following the Fontan procedure: increased factor VIII may predispose to thrombosis. J Thorac Cardiovasc Surg 125 (2003) 1260-1267
15. Monagle P., Barnes C., Ignjatovic V., Furmedge J., Newall F., Chan A., et al. Developmental haemostasis. Impact for clinical haemostasis laboratories. Thromb Haemost 95 (2006) 362-372
16. Andrew M., Paes B., Milner R., Johnston M., Mitchell L., Tollefsen D.M., et al. Development of the human coagulation system in the full-term infant. Blood 70 (1987) 165-172
17. Odegard K.C., Zurakowski D., Hornykewycz S., DiNardo J.A., Castro R.A., Neufeld E.J., et al. Evaluation of the coagulation system in children with two-ventricle congenital heart disease. Ann Thorac Surg 83 (2007) 1797-1803
18. Cabral H.J. Multiple comparisons procedures. Circulation 117 (2008) 698-701
19. Fitzmaurice G.M., Laird N.M., and Ware J.H. Applied longitudinal analysis (2004), Wiley, New York p. 49-86
20. Coon P.D., Rychik J., Novello R.T., Ro P.S., Gaynor J.W., and Spray T.L. Thrombus formation after the Fontan operation. Ann Thorac Surg 71 (2001) 1990-1994
21. Kaulitz R., Ziemer G., Rauch R., Girisch M., Bertram H., Wessel A., et al. Prophylaxis of thromboembolic complications after the Fontan operation (total cavopulmonary anastomosis). J Thorac Cardiovasc Surg 129 (2005) 569-575
22. Monagle P., Chan A., Massicotte P., Chalmers E., and Michelson A.D. Antithrombotic therapy in children: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 126 (2004) 645S-687S
23. Gersony W.M. Fontan operation after 3 decades: what we have learned. Circulation 117 (2008) 13-15
24. Jacobs M.L., Pourmoghadam K.K., Geary E.M., Reyes A.T., Madan N., McGrath L.B., et al. Fontan's operation: is aspirin enough? Is Coumadin too much?. Ann Thorac Surg 73 (2002) 64-68
25. Monagle P., Chalmers E., Chan A., DeVeber G., Kirkham F., Massicotte P., et al. Antithrombotic therapy in neonates and children: American College of Chest Physicians evidence-based clinical practice guidelines (8th edition). Chest 133 (2008) 887S-968S
26. Jacobs M.L., and Pourmoghadam K.K. Thromboembolism and the role of anticoagulation in the Fontan patient. Pediatr Cardiol 28 (2007) 457-464
27. Rauch R., Ries M., Hofbeck M., Buheitel G., Singer H., and Klinge J. Hemostatic changes following the modified Fontan operation (total cavopulmonary connection). Thromb Haemost 83 (2000) 678-682
28. Andrew M., Vegh P., Johnston M., Bowker J., Ofosu F., and Mitchell L. Maturation of the hemostatic system during childhood. Blood 80 (1992) 1998-2005
29. O'Donnell J., and Laffan M.A. The relationship between ABO histo-blood group, factor VIII and von Willebrand factor. Transfus Med 11 (2001) 343-351
30. Kamphuisen P.W., Eikenboom J.C., Rosendaal F.R., Koster T., Blann A.D., Vos H.L., et al. High factor VIII antigen levels increase the risk of venous thrombosis but are not associated with polymorphisms in the von Willebrand factor and factor VIII gene. Br J Haematol 115 (2001) 156-158
31. Kraaijenhagen R.A., in't Anker P.S., Koopman M.M., Reitsma P.H., Prins M.H., van den Ende A., et al. High plasma concentration of factor VIIIc is a major risk factor for venous thromboembolism. Thromb Haemost 83 (2000) 5-9
32. Koster T., Blann A.D., Briet E., Vandenbroucke J.P., and Rosendaal F.R. Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep-vein thrombosis. Lancet 345 (1995) 152-155
33. Goldenberg N.A., Knapp-Clevenger R., and Manco-Johnson M.J. Elevated plasma factor VIII and D-dimer levels as predictors of poor outcomes of thrombosis in children. N Engl J Med 351 (2004) 1081-1088
34. Hollestelle M.J., Geertzen H.G., Straatsburg I.H., van Gulik T.M., and van Mourik J.A. Factor VIII expression in liver disease. Thromb Haemost 91 (2004) 267-275
35. Hollestelle M.J., Poyck P.P., Hollestelle J.M., Marsman H.A., Mourik J.A., and Gulik T.M. Extra-hepatic factor VIII expression in porcine fulminant hepatic failure. J Thromb Haemost 3 (2005) 2274-2280
36. Hollestelle M.J., Thinnes T., Crain K., Stiko A., Kruijt J.K., van Berkel T.J., et al. Tissue distribution of factor VIII gene expression in vivo-a closer look. Thromb Haemost 86 (2001) 855-861
37. Friedrich-Rust M., Koch C., Rentzsch A., Sarrazin C., Schwarz P., Herrmann E., et al. Noninvasive assessment of liver fibrosis in patients with Fontan circulation using transient elastography and biochemical fibrosis markers. J Thorac Cardiovasc Surg 135 (2008) 560-567